Stanley Druckenmiller: portfolio of Duquesne Family Office

Stanley Druckenmiller manages his own wealth through the Duquesne Family Office; earlier he ran the macro fund Duquesne Capital.

Source: 13F filing with the US Securities and Exchange Commission dated Feb 12, 2015. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q4 2014. Go to the latest filing (Q3 2026)

1.0B USDQ4 2014
Total value of stock positions
1.0B USD
Positions
35
Share of the ten largest
55.3%

The ten largest positions Q4 2014

  1. Biogen 12.0%▲ +246.2%
  2. Illumina, Inc. 7.4%unchanged
  3. Target Corporation 5.7%▲ +143.5%
  4. Home Depot (The) 5.4%▲ +137.9%
  5. HDFC Bank Ltd 5.0%▲ +228.0%
  6. Celgene Corp 4.8%▼ −22.6%
  7. Lowe's 4.5%▲ +80.4%
  8. Costco 4.0%▲ +80.3%
  9. Nordstrom Inc 3.3%▲ +199.9%
  10. Meta Platforms 3.3%new
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 4.5B USD).
Choose a quarter (54 filings)

All positions Q4 2014

Positions Q4 2014 per 13F filing, 17 of 17
Symbol Weight in previous quarter Shares in previous quarter Value in previous quarter Change
Google Inc 12.0% 166,810 98.2M USD sold out
Walgreen Co 4.7% 648,000 38.4M USD sold out
Mkt Vctrs Gld Miners ETF 4.1% 1,546,600 33.0M USD sold out
McDermott Int'l Inc 3.2% 4,555,000 26.1M USD sold out
Cameco Corp 3.1% 1,428,200 25.2M USD sold out
GILD Gilead Sciences 2.8% 217,500 23.2M USD sold out
AMGN Amgen 2.7% 158,900 22.3M USD sold out
MRK Merck & Co. 2.4% 329,600 19.5M USD sold out
Mellanox Tech's Ltd 2.1% 389,300 17.5M USD sold out
VRTX Vertex Pharmaceuticals 2.0% 146,600 16.5M USD sold out
SCHW Charles Schwab Corporation 1.8% 485,700 14.3M USD sold out
Hlth Care Slct Sctr SPDR 1.4% 172,300 11.0M USD sold out
Fin'l Slct Sctr SPDR Fnd 1.2% 428,700 9.9M USD sold out
SPDR D.J. Ind'l Avg ETF Tst 1.2% 58,300 9.9M USD sold out
ARIAD Pharms Inc 1.1% 1,645,000 8.9M USD sold out
NewLink Genetics Corp 0.5% 182,500 3.9M USD sold out
Kite Pharma Inc 0.1% 40,000 1.1M USD sold out

Breakdown by sector

  • Health Care 19.4%
  • Consumer Discretionary 12.5%
  • Consumer Staples 9.6%
  • Financials 7.5%
  • Technology 4.6%
  • Communication Services 3.3%
  • Industrials 3.1%
  • Real Estate 0.9%
  • not in our coverage 39.1%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close